Exercise of Nil Cost Options under PSP

RNS Number : 9148I
Assura PLC
13 August 2019
 

13 August 2019

 

Assura plc

 

Exercise of Nil Cost Options under PSP

 

Assura plc ("Assura"), the leading primary care property investor and developer announces that on 12 August 2019, Jonathan Murphy exercised his 2016 PSP awards.

 

The table below shows the number of shares vesting to Mr Murphy, the number of shares sold to satisfy income tax and national insurance liabilities and the number of shares he will receive following the sale.

 


Number of

Shares awarded

Number of shares sold to satisfy income tax and national insurance liabilities

Additional shares sold

Number of shares after shares sold

 

Jonathan Murphy (CEO)

218,950

(102,907)

nil

116,044

 

The Remuneration Committee of Assura had previously agreed that sufficient shares may be sold by PDMRs to cover the arising income tax and national insurance liabilities. The relevant market price for taxation purposes is £0.651 per share.

 

As a result of the above, the increase in Mr Murphy's shareholding is as follows:

 


Shareholding on

9 August 2019

Shareholding

 post exercise

Jonathan Murphy (CEO)

                         2,393,349

                       2,509,393

 

Following the allotment of shares Mr Murphy transferred 98,250 shares into his SIPP. His total beneficial holding remains the same.

The Notification of Dealing Form for the PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

 

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

 Vesting of share awards under PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

 

218,950

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

N/A

e)

Date of the transaction

 

12 August 2019

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Sale of 102,907 shares to satisfy tax and national insurance liabilities.

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.651 GBP

 

 

102,907

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.651 GBP

 

 

102,907

 

£66,992.46

e)

Date of the transaction

 

13 August 2019

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Transfer of 98,250 shares to Mr Murphy's SIPP.

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.651 GBP

 

 

98,250

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.651 GBP

 

 

98,250

 

£63,960.75

e)

Date of the transaction

 

13 August 2019

f)

Place of the transaction

 

XLON

 

 

 

- Ends -

 

For more information, please contact:

Assura plc

Tel: 01925 420660

Orla Ball, Company Secretary


David Purcell, Head of Financial Reporting


Finsbury

Tel: 0207 251 3801

Gordon Simpson


 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGGURURUPBGAW

Companies

Assura (AGR)
UK 100